In the hippocampus of PD patients, where we detected the main changes in CD200R1 and CD200 expression, alpha-synuclein pathology and alterations in the cholinergic activity and in the expression of pro-inflammatory markers have been described44–46. The gene discussed is CD200; the disease is Parkinson disease.